The Effect of REcombinant Human Thrombopoietin (rhTPO) on Sepsis Patients With aCUte Severe thrombocytopEnia (RESCUE)
The Effect of Recombinant Human Thrombopoietin(rhTPO) on Sepsis Patients With Acute Severe Thrombocytopenia：a Prospective, Multi-center, Open-label, ,Randomized, Controlled Trial
Sponsor: Changhai Hospital
This PHASE2/PHASE3 trial investigates Sepsis and Thrombocytopenia and is currently actively recruiting participants. Changhai Hospital leads this study, which shows 12 recorded versions since 2019 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Jun 2025 — Present [monthly]
Recruiting PHASE2/PHASE3
-
Sep 2024 — Jun 2025 [monthly]
Recruiting PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE2_PHASE3
-
Nov 2022 — May 2024 [monthly]
Recruiting PHASE2_PHASE3
▶ Show 7 earlier versions
-
Oct 2021 — Nov 2022 [monthly]
Recruiting PHASE2_PHASE3
-
Mar 2021 — Oct 2021 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2021 — Mar 2021 [monthly]
Recruiting PHASE2_PHASE3
-
May 2019 — Jan 2021 [monthly]
Recruiting PHASE2_PHASE3
Status: Not Yet Recruiting → Recruiting
-
Oct 2018 — May 2019 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jun 2018 — Oct 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Not Yet Recruiting PHASE2_PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Changhai Hospital
- Fudan University
- Huadong Hospital
- Ruilan Wang
- Second Affiliated Hospital of Nanchang University
- Shanghai Jiao Tong University School of Medicine
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Shanghai University of Traditional Chinese Medicine
For direct contact, visit the study record on ClinicalTrials.gov .